The US Food and Drug Administration is charged with the task of approving and regulating medication in our country. They weigh in on clinical trials, warning labels and advertising and compile complaints that are made about drugs. In 2011, the FDA approved the medication rivaroxaban, commonly known as Xarelto. Xarelto is used to prevent strokes in patients with atrial fibrillation. It is also used to treat DVT or deep vein thrombosis and pulmonary embolism. Xarelto was initially approved to prevent blood clots from forming in patients who need hip or knee surgery and continues to serve this purpose. All blood thinners may cause patients to suffer from internal bleeding, and Xarelto is no different. Internal bleeding is one of the risks of taking it. However, as of January, 2015, there is no approved drug or practice to reverse the bleeding. Researchers are working hard to develop an antidote that can reverse the anti-coagulant effects of Xarelto, and one may be coming soon. Sadly, it is too late for many.
Attorneys are filing cases on behalf of patients and families who have suffered because of uncontrollable bleeding and other complications associated with Xarelto. If you are experiencing emotional or physical trauma because of Xarelto and its side effects, please contact the Birmingham, Alabama attorneys at Farris Riley & Pitt. We have the experience you need to get the financial recovery you deserve.
Xarelto Multi-District Litigation
Plaintiffs have filed numerous lawsuits in courts around the country alleging injury from Xarelto and requesting monetary damages. In December, 2014 a judicial panel decided to consolidate all pending federal Xarelto lawsuits into a single MDL (Multi-District Litigation) for the purpose of conducting coordinated pre-trial proceedings. Judges often create an MDL when there are multiple lawsuits against a single pharmaceutical company. Often, the cases have similar issues at their heart. Consolidating them saves everyone time and money especially during the discovery phase when parties exchange volumes of documents and information. As of January 15, 2015, approximately 85 cases are currently consolidated in the US District Court, Eastern District of Louisiana. That number is expected to grow as more people learn of the MDL.
Xarelto Lawsuit Claims
Janssen Pharmaceuticals, a division of Johnson & Johnson, and Bayer manufacture and market Xarelto. Common issues in the lawsuits surround the allegation that Janssen and Bayer wrongfully marketed Xarelto. The marketing claims state that patients suffered injuries because the manufacturer aggressively and improperly marketed it as superior to warfarin. This allegation is important because warfarin was nearly the only prescribed anti-coagulant since the mid 1900s. It works well as a blood thinner but is inconvenient to take. Xarelto was supposed to be “easier” to take and provide superior benefits than warfarin. The lawsuits allege that the manufacturer made these claims, even though they knew that patients taking Xarelto had higher rates of gastrointestinal bleeds than patients taking warfarin.
The lawsuits also include allegations that the manufacturer did not provide consumers or medical professionals with honest information. There are claims of misleading information, inadequate warnings, improper labels, and increased risks of dangerous side effects. Most lawsuits allege that the manufacturer knew or should have known about the risks of taking Xarelto and that they did not provide adequate warnings about those risks.
Furthermore, some Plaintiff’s claim that in addition to the above “violations”, the lack of an antidote made Xarelto unacceptably dangerous to distribute Xarelto at all. For some plaintiffs who claim that they suffered from uncontrollable bleeding, the lack of an approved antidote to correct the bleeding is central to their cases.
Injuries from Xarelto
Every lawsuit for damages must involve an injury for which someone seeks compensation. In each Xarelto lawsuit currently pending, the plaintiff claims that they or a loved one has suffered because of Xarelto. Patients claim that they have experienced gastrointestinal bleeding, brain bleeding and other side effects that have resulted in financial hardship and emotional distress. Others claim that they lost loved ones because of Xarelto injuries like hemorrhagic brain bleeds that caused their death. Each Plaintiff in these cases seeks monetary compensation for things like medical expenses, loss of income, or emotional distress. In cases involving the loss of a loved one, some ask for funeral expenses and pain and suffering.
If you think you have a claim because you or someone you love suffered from uncontrollable bleeding or other injuries while taking Xarelto, it is important that you contact the attorneys at Farris Riley & Pitt quickly. Every state has time limits during which you may file a lawsuit called the statute of limitations. We have no way of knowing if the statute of limitations has expired until we review the facts of your specific case. Our attorneys have all the experience you need for a Birmingham, Alabama pharmaceutical Xareltoclaim and can help get you the financial compensation you deserve.